Literature DB >> 34244322

Response to Letter to the Editor ERJ-00920-2021.

Jose L Izquierdo1,2, Joan B Soriano3,4,5.   

Abstract

Entities:  

Year:  2021        PMID： 34244322      PMCID： PMC8287737          DOI： 10.1183/13993003.01076-2021

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  3 in total

1.  Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology.

Authors:  Daniele Pala; Marco Pistis
Journal:  Front Pharmacol       Date:  2021-03-09       Impact factor: 5.810

2.  Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights.

Authors:  Peter Ab Wark; Prabuddha S Pathinayake; Mathew Suji Eapen; Sukhwinder Singh Sohal
Journal:  Eur Respir J       Date:  2021-07-08       Impact factor: 16.671

3.  The impact of COVID-19 on patients with asthma.

Authors:  José Luis Izquierdo; Carlos Almonacid; Yolanda González; Carlos Del Rio-Bermudez; Julio Ancochea; Remedios Cárdenas; Sara Lumbreras; Joan B Soriano
Journal:  Eur Respir J       Date:  2021-03-04       Impact factor: 16.671
  3 in total
  1 in total

1.  Inhaled corticosteroids do not affect the antibody titer against the SARS-CoV-2 spike protein in BNT162b2 mRNA vaccinated patients.

Authors:  Takeo Nakajima; Tatsuya Nagano; Yoshiharu Miyata; Shoko Murakami; Satoshi Mitsuyuki; Yohei Funakoshi; Kimikazu Yakushijin; Hitoshi Horimoto; Yoshihiro Nishimura; Kazuyuki Kobayashi
Journal:  Allergy Asthma Clin Immunol       Date:  2022-08-25       Impact factor: 3.373
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.